enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025)
enVVeno Medical (NVNO) posted quarterly Cash from Financing Activities of $782000.0 for Q4 2025, down 94.25% quarter-over-quarter from $13.6 million in Q3 2024.
enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025) Analysis & Trends
enVVeno Medical's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $782000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities changed N/A year-over-year to $782000.0; the TTM figure through Dec 2025 stood at $14.4 million (up 5.4% YoY), while the FY2025 annual figure was $1.0 million, down 92.5% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $782000.0, down from $13.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $38.4 million in Q1 2021, with the low at -$4000.0 in Q4 2021.
- The 3-year median for Cash from Financing Activities is $7.2 million (2024), against an average of $12.0 million.
- Peak annual rise in Cash from Financing Activities reached 6627.2% in 2021, while the deepest fall reached 100.06% in 2021.
- enVVeno Medical's Cash from Financing Activities stood at -$4000.0 in 2021, then surged by 339875.0% to $13.6 million in 2024, then sank by 94.25% to $782000.0 in 2025.
- Business Quant data shows NVNO's Cash from Financing Activities at $782000.0 in Q4 2025, $13.6 million in Q3 2024, and $46000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | enVVeno Medical | 7.05 Mn | 7.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 782,000.00 |
| Dec 31, 2025 | 782,000.00 |
| Sep 30, 2024 | 13.59 Mn |
| Sep 30, 2024 | 13.59 Mn |
| Mar 31, 2024 | 46,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 19.24 Mn |
| Sep 30, 2021 | 19.24 Mn |
| Mar 31, 2021 | 38.37 Mn |
| Mar 31, 2021 | 38.37 Mn |
| Dec 31, 2020 | 6.35 Mn |
| Dec 31, 2020 | 6.35 Mn |
| Sep 30, 2020 | 5.87 Mn |
| Sep 30, 2020 | 5.87 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Mar 31, 2020 | 570,341.00 |
| Mar 31, 2020 | 570,341.00 |